Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Serum Cartilage Oligomeric Matrix Protein Accumulation Decreases Significantly After 12 Weeks of Running

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Feza Korkusuz, Middle East Technical University
ClinicalTrials.gov Identifier:
NCT01576159
First received: April 9, 2012
Last updated: April 12, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2008
  Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)